Many of these aggressive thyroid cancers do not concentrate radioactive iodide from the lack of the sodium/iodide symporter (SLC5A5) [7, 8, 9], resulting in decreased survival [8, 10]. This evidence concerns the gene SLC5A5 and thyroid cancer.